12 results
Search Results
2. Comprehensive pathway enrichment analysis workflows: COVID-19 case study.
- Author
-
Agapito, Giuseppe, Pastrello, Chiara, and Jurisica, Igor
- Subjects
COVID-19 ,SARS-CoV-2 ,CURING ,PANDEMICS ,SOFTWARE development tools - Abstract
The coronavirus disease 2019 (COVID-19) outbreak due to the novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been classified as a pandemic disease by the World Health Organization on the 12th March 2020. This world-wide crisis created an urgent need to identify effective countermeasures against SARS-CoV-2. In silico methods, artificial intelligence and bioinformatics analysis pipelines provide effective and useful infrastructure for comprehensive interrogation and interpretation of available data, helping to find biomarkers, explainable models and eventually cures. One class of such tools, pathway enrichment analysis (PEA) methods, helps researchers to find possible key targets present in biological pathways of host cells that are targeted by SARS-CoV-2. Since many software tools are available, it is not easy for non-computational users to choose the best one for their needs. In this paper, we highlight how to choose the most suitable PEA method based on the type of COVID-19 data to analyze. We aim to provide a comprehensive overview of PEA techniques and the tools that implement them. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview.
- Author
-
Dagliati, Arianna, Malovini, Alberto, Tibollo, Valentina, and Bellazzi, Riccardo
- Subjects
COVID-19 pandemic ,COVID-19 ,INFORMATION sharing ,MEDICAL informatics ,PANDEMICS ,ELECTRONIC health records ,DRUG efficacy - Abstract
The coronavirus disease 2019 (COVID-19) pandemic has clearly shown that major challenges and threats for humankind need to be addressed with global answers and shared decisions. Data and their analytics are crucial components of such decision-making activities. Rather interestingly, one of the most difficult aspects is reusing and sharing of accurate and detailed clinical data collected by Electronic Health Records (EHR), even if these data have a paramount importance. EHR data, in fact, are not only essential for supporting day-by-day activities, but also they can leverage research and support critical decisions about effectiveness of drugs and therapeutic strategies. In this paper, we will concentrate our attention on collaborative data infrastructures to support COVID-19 research and on the open issues of data sharing and data governance that COVID-19 had made emerge. Data interoperability, healthcare processes modelling and representation, shared procedures to deal with different data privacy regulations, and data stewardship and governance are seen as the most important aspects to boost collaborative research. Lessons learned from COVID-19 pandemic can be a strong element to improve international research and our future capability of dealing with fast developing emergencies and needs, which are likely to be more frequent in the future in our connected and intertwined world. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Robots as intelligent assistants to face COVID-19 pandemic.
- Author
-
Seidita, Valeria, Lanza, Francesco, Pipitone, Arianna, and Chella, Antonio
- Subjects
COVID-19 pandemic ,SARS-CoV-2 ,ROBOTS ,COVID-19 ,TECHNOLOGICAL progress ,PANDEMICS - Abstract
Motivation The epidemic at the beginning of this year, due to a new virus in the coronavirus family, is causing many deaths and is bringing the world economy to its knees. Moreover, situations of this kind are historically cyclical. The symptoms and treatment of infected patients are, for better or worse even for new viruses, always the same: more or less severe flu symptoms, isolation and full hygiene. By now man has learned how to manage epidemic situations, but deaths and negative effects continue to occur. What about technology? What effect has the actual technological progress we have achieved? In this review, we wonder about the role of robotics in the fight against COVID. It presents the analysis of scientific articles, industrial initiatives and project calls for applications from March to now highlighting how much robotics was ready to face this situation, what is expected from robots and what remains to do. Results The analysis was made by focusing on what research groups offer as a means of support for therapies and prevention actions. We then reported some remarks on what we think is the state of maturity of robotics in dealing with situations like COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.
- Author
-
Das, Jayanta Kumar, Tradigo, Giuseppe, Veltri, Pierangelo, Guzzi, Pietro H, and Roy, Swarup
- Subjects
DATA science ,COVID-19 testing ,COVID-19 pandemic ,COVID-19 ,PANDEMICS ,SARS-CoV-2 - Abstract
Motivation The outbreak of novel severe acute respiratory syndrome coronavirus (SARS-CoV-2, also known as COVID-19) in Wuhan has attracted worldwide attention. SARS-CoV-2 causes severe inflammation, which can be fatal. Consequently, there has been a massive and rapid growth in research aimed at throwing light on the mechanisms of infection and the progression of the disease. With regard to this data science is playing a pivotal role in in silico analysis to gain insights into SARS-CoV-2 and the outbreak of COVID-19 in order to forecast, diagnose and come up with a drug to tackle the virus. The availability of large multiomics, radiological, bio-molecular and medical datasets requires the development of novel exploratory and predictive models, or the customisation of existing ones in order to fit the current problem. The high number of approaches generates the need for surveys to guide data scientists and medical practitioners in selecting the right tools to manage their clinical data. Results Focusing on data science methodologies, we conduct a detailed study on the state-of-the-art of works tackling the current pandemic scenario. We consider various current COVID-19 data analytic domains such as phylogenetic analysis, SARS-CoV-2 genome identification, protein structure prediction, host–viral protein interactomics, clinical imaging, epidemiological research and drug discovery. We highlight data types and instances, their generation pipelines and the data science models currently in use. The current study should give a detailed sketch of the road map towards handling COVID-19 like situations by leveraging data science experts in choosing the right tools. We also summarise our review focusing on prime challenges and possible future research directions. Contact hguzzi@unicz.it , sroy01@cus.ac.in [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. DrugRepV: a compendium of repurposed drugs and chemicals targeting epidemic and pandemic viruses.
- Author
-
Rajput, Akanksha, Kumar, Archit, Megha, Kirti, Thakur, Anamika, and Kumar, Manoj
- Subjects
EPIDEMICS ,VIRUSES ,PANDEMICS ,LITERARY form ,INTERNET servers ,CLINICAL drug trials ,SCIENTIFIC community - Abstract
Viruses are responsible for causing various epidemics and pandemics with a high mortality rate e.g. ongoing SARS-CoronaVirus-2 crisis. The discovery of novel antivirals remains a challenge but drug repurposing is emerging as a potential solution to develop antivirals in a cost-effective manner. In this regard, we collated the information of repurposed drugs tested for antiviral activity from literature and presented it in the form of a user-friendly web server named 'DrugRepV'. The database contains 8485 entries (3448 unique) with biological, chemical, clinical and structural information of 23 viruses responsible to cause epidemics/pandemics. The database harbors browse and search options to explore the repurposed drug entries. The data can be explored by some important fields like drugs, viruses, drug targets, clinical trials, assays, etc. For summarizing the data, we provide overall statistics of the repurposed candidates. To make the database more informative, it is hyperlinked to various external repositories like DrugBank, PubChem, NCBI-Taxonomy, Clinicaltrials.gov , World Health Organization and many more. 'DrugRepV' database (https://bioinfo.imtech.res.in/manojk/drugrepv/) would be highly useful to the research community working to develop antivirals. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. A review on viral data sources and search systems for perspective mitigation of COVID-19.
- Author
-
Bernasconi, Anna, Canakoglu, Arif, Masseroli, Marco, Pinoli, Pietro, and Ceri, Stefano
- Subjects
COVID-19 ,COVID-19 pandemic ,METADATA ,PANDEMICS ,SARS-CoV-2 ,DISEASE outbreaks ,DATA integration - Abstract
With the outbreak of the COVID-19 disease, the research community is producing unprecedented efforts dedicated to better understand and mitigate the effects of the pandemic. In this context, we review the data integration efforts required for accessing and searching genome sequences and metadata of SARS-CoV2, the virus responsible for the COVID-19 disease, which have been deposited into the most important repositories of viral sequences. Organizations that were already present in the virus domain are now dedicating special interest to the emergence of COVID-19 pandemics, by emphasizing specific SARS-CoV2 data and services. At the same time, novel organizations and resources were born in this critical period to serve specifically the purposes of COVID-19 mitigation while setting the research ground for contrasting possible future pandemics. Accessibility and integration of viral sequence data, possibly in conjunction with the human host genotype and clinical data, are paramount to better understand the COVID-19 disease and mitigate its effects. Few examples of host-pathogen integrated datasets exist so far, but we expect them to grow together with the knowledge of COVID-19 disease; once such datasets will be available, useful integrative surveillance mechanisms can be put in place by observing how common variants distribute in time and space, relating them to the phenotypic impact evidenced in the literature. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus.
- Author
-
Li, Shasha, Liu, Wenli, Chen, Yangzhen, Wang, Liqin, An, Wenlin, An, Xiaoping, Song, Lihua, Tong, Yigang, Fan, Huahao, and Lu, Chenyang
- Subjects
COVID-19 ,MONONUCLEAR leukocytes ,MEDICAL botany ,COVID-19 pandemic ,UNFOLDED protein response ,PANDEMICS ,ENDOPLASMIC reticulum - Abstract
Antiviral therapies targeting the pandemic coronavirus disease 2019 (COVID-19) are urgently required. We studied an already-approved botanical drug cepharanthine (CEP) in a cell culture model of GX_P2V, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related virus. RNA-sequencing results showed the virus perturbed the expression of multiple genes including those associated with cellular stress responses such as endoplasmic reticulum (ER) stress and heat shock factor 1 (HSF1)-mediated heat shock response, of which heat shock response-related genes and pathways were at the core. CEP was potent to reverse most dysregulated genes and pathways in infected cells including ER stress/unfolded protein response and HSF1-mediated heat shock response. Additionally, single-cell transcriptomes also confirmed that genes of cellular stress responses and autophagy pathways were enriched in several peripheral blood mononuclear cells populations from COVID-19 patients. In summary, this study uncovered the transcriptome of a SARS-CoV-2-related coronavirus infection model and anti-viral activities of CEP, providing evidence for CEP as a promising therapeutic option for SARS-CoV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. A review on drug repurposing applicable to COVID-19.
- Author
-
Dotolo, Serena, Marabotti, Anna, Facchiano, Angelo, and Tagliaferri, Roberto
- Subjects
COVID-19 ,PANDEMICS ,DRUG prices ,ARTIFICIAL intelligence - Abstract
Drug repurposing involves the identification of new applications for existing drugs at a lower cost and in a shorter time. There are different computational drug-repurposing strategies and some of these approaches have been applied to the coronavirus disease 2019 (COVID-19) pandemic. Computational drug-repositioning approaches applied to COVID-19 can be broadly categorized into (i) network-based models, (ii) structure-based approaches and (iii) artificial intelligence (AI) approaches. Network-based approaches are divided into two categories: network-based clustering approaches and network-based propagation approaches. Both of them allowed to annotate some important patterns, to identify proteins that are functionally associated with COVID-19 and to discover novel drug–disease or drug–target relationships useful for new therapies. Structure-based approaches allowed to identify small chemical compounds able to bind macromolecular targets to evaluate how a chemical compound can interact with the biological counterpart, trying to find new applications for existing drugs. AI-based networks appear, at the moment, less relevant since they need more data for their application. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Web tools to fight pandemics: the COVID-19 experience.
- Author
-
Mercatelli, Daniele, Holding, Andrew N, and Giorgi, Federico M
- Subjects
COVID-19 pandemic ,COVID-19 ,PANDEMICS ,GENOMICS ,SARS-CoV-2 ,EPIDEMIOLOGY - Abstract
The current outbreak of COVID-19 has generated an unprecedented scientific response worldwide, with the generation of vast amounts of publicly available epidemiological, biological and clinical data. Bioinformatics scientists have quickly produced online methods to provide non-computational users with the opportunity of analyzing such data. In this review, we report the results of this effort, by cataloguing the currently most popular web tools for COVID-19 research and analysis. Our focus was driven on tools drawing data from the fields of epidemiology, genomics, interactomics and pharmacology, in order to provide a meaningful depiction of the current state of the art of COVID-19 online resources. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.
- Author
-
Hufsky, Franziska, Lamkiewicz, Kevin, Almeida, Alexandre, Aouacheria, Abdel, Arighi, Cecilia, Bateman, Alex, Baumbach, Jan, Beerenwinkel, Niko, Brandt, Christian, Cacciabue, Marco, Chuguransky, Sara, Drechsel, Oliver, Finn, Robert D, Fritz, Adrian, Fuchs, Stephan, Hattab, Georges, Hauschild, Anne-Christin, Heider, Dominik, Hoffmann, Marie, and Hölzer, Martin
- Subjects
SARS-CoV-2 ,COVID-19 ,PANDEMICS ,COVID-19 pandemic ,COVID-19 treatment ,COMMUNICABLE diseases - Abstract
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus of the family Coronaviridae. The virus causes the infectious disease COVID-19. The biology of coronaviruses has been studied for many years. However, bioinformatics tools designed explicitly for SARS-CoV-2 have only recently been developed as a rapid reaction to the need for fast detection, understanding and treatment of COVID-19. To control the ongoing COVID-19 pandemic, it is of utmost importance to get insight into the evolution and pathogenesis of the virus. In this review, we cover bioinformatics workflows and tools for the routine detection of SARS-CoV-2 infection, the reliable analysis of sequencing data, the tracking of the COVID-19 pandemic and evaluation of containment measures, the study of coronavirus evolution, the discovery of potential drug targets and development of therapeutic strategies. For each tool, we briefly describe its use case and how it advances research specifically for SARS-CoV-2. All tools are free to use and available online, either through web applications or public code repositories. Contact: evbc@unj-jena.de [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Bioinformatics helping to mitigate the impact of COVID-19 – Editorial.
- Author
-
Cannataro, Mario and Harrison, Andrew
- Subjects
COVID-19 ,PANDEMICS ,PHARMACOGENOMICS ,COVID-19 pandemic ,BIOINFORMATICS ,SCIENTIFIC literature - Abstract
COVID-19 biomarkers,drug targets and bioinformatics approaches for drug repurposing The identification of COVID-19 biomarkers, the discovery of therapeutictargetsfordrugsandthebioinformaticsapproaches fordrugrepurposingarekeyresearchtopicstoaddressforfacing the COVID-19 disease. Bioinformatics tools and resources for SARS-CoV-2 and COVID-19 research Next-generationsequencingisthecentraltechnologyfordetecting genomes of SARS-CoV-2 that provides the basic data about the virus. Bioinformatics helping to mitigate the impact of COVID-19 - Editorial. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.